Coronavirus Vaccine Update
Coronavirus Vaccine Updates
 |
| Coronavirus Vaccine Updates |
The corona virus is the world's deadliest epidemic, killing millions of people every day.
Researchers around the world are working day and night to find a vaccine for the corona virus. About 200 groups around the world are working on vaccines. At present, 41 vaccine candidates are in human clinical trials.
Coronavirus Vaccine Updates
Indian Coronavirus Vaccine Updates:
The human trials of India’s indigenous COVAXIN are set to begin in AIIMS-Delhi, Redkar Hospital in Goa and Bhubaneswar’s Institute of Medical Sciences and SUM Hospital. The clinical trials of the potential vaccine, which is being developed by the Indian Council for Medical Research (ICMR), Bharat Biotech International Limited (BBIL), and National Institute of Virology, Pune, has begun at AIIMS Patna and PGI Rohtak. AIIMS-Delhi has begun the process of recruiting volunteers for conducting human clinical trials of the indigenously developed Covid-19 vaccine candidate Covaxin, the premier medical institute's director Dr Randeep Guleria said.
AIIMS-Delhi is among the 12 sites selected by the Indian Council for Medical Research (ICMR) for conducting Phase I and II randomised, double-blind and placebo-controlled clinical trials of Covaxin.
In phase I, the vaccine would be tested on 375 volunteers and 100 of them, the highest, would be from AIIMS. The second phase, would include around 750 volunteers from all 12 sites put together.
Clinical trials of the Covaxin will also begin at Medical institutes and hospitals located in Visakhapatnam, Belgaum in Karnataka, Nagpur, Uttar Pradesh’s Gorakhpur and Kanpur, Tamil Nadu’s Kattankulathur, Hyderabad, and Arya Nagar.
UK's Oxford Coronavirus Vaccine Update :
Oxford-AstraZeneca’s endeavour to develop a potential Coronavirus vaccine has been a ray of hope to the world.
The human trial of COVID-19 vaccine candidate developed by the University of Oxford and backed by AstraZeneca Plc has shown a positive result. Officially known as AZD1222, the vaccine has prompted a protective immune response in hundreds of people who got the shot, according to a report published in British medical journal Lancet.
The preliminary results of the Phase-I and -II trials, published in The Lancet journal, involved 1,107 healthy adults, and found that the vaccine induced an immune response, both via antibodies and the T-cells of the immune system, up to day 56 of the ongoing trial. The report stated that the potential coronavirus vaccine candidate “safe, well-tolerated and immunogenic.”
Russia's Coronavirus Vaccine Update :
Russia has been claiming that the “World’s first Coronavirus COVID vaccine” would be ready by August.
Russia’s health minister Mikhail Murashko has revealed that the vaccine that his country is currently developing to prevent Covid-19 will be available for public consumption by next month after it completes the last stage of clinical trials.
Officials in Moscow earlier said that the “civil distribution” of the coronavirus vaccine could begin by mid-August and mass production in September. Russia has also planned to produce 30 million doses of the potential COVID19 vaccine domestically in 2020, with the potential to manufacture a further 170 million abroad, as per the Reuters report.
Recently, Russia’s Sechenov University had announced that it had completed clinical trials of a Covid-19 vaccine, developed by Russian defense ministry’s Gamalei Institute of Epidemiology and Microbiology.
USA Coronavirus Vaccine Update :
US-based Moderna is developing a potential Coronavirus vaccine candidate. The vaccine, developed by the U.S. National Institutes of Health and Moderna Inc., will be tested in 30,000 volunteers on July 27.
Moderna said it already has made enough doses for the pivotal late-stage testing. Still needed before those injections begin: results of how the shot has fared in smaller, earlier-stage studies.
But Moderna’s announcement suggests those studies are making enough progress for the company and the NIH to get ready to move ahead.
More :
Awesome information
ReplyDeleteUseful information 👌👍
ReplyDelete